Skip to product information

UCSF 39th Annual Cardiology for the Practitioner 2025 PDFs Only

UCSF 39th Annual Cardiology for the Practitioner 2025 PDFs Only

Regular price $10.00 USD
Regular price $10.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
UCSF 39th Annual Cardiology for the Practitioner 2025 PDFs Only

UCSF 39th Annual Cardiology for the Practitioner 2025 PDFs Only

Regular price $10.00
Regular price $10.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    UCSF 39th Annual Cardiology for the Practitioner 2025 PDFs Only

    This course only has PDFs no videos are recorded and uploaded for this

    Overview


    This three-day symposium is an intensive course designed for internists, primary care physicians, family practitioners, cardiologists, and other health care providers who encounter patients with various heart diseases. This years program will emphasize the importance of Obesity and CVD/Heart failure and review of current & emerging therapies for weight management in clinical practice. There will also be emphasis on current and emerging therapies for various lipid disorders as well as Structural heart disorders. During the 3 days, these will be discussed in detail as well as recent advances in pathophysiology, therapeutic considerations, and clinical relevance of common cardiovascular disorders will be presented.

    Emphasis will be placed on the recent practice guidelines and updates for common cardiovascular conditions. The entire course will focus on frequently encountered clinical problems in cardiac patients by practicing physicians. • There will be state-of-the-art and comprehensive reviews on the evaluation and management of coronary risk factors, hypertension, hyperlipidemia, diabetes, and coronary artery disease, syncope, atrial fibrillation, valvular heart disease. Special focus will be placed on review of traditional and emerging cardiac risk factors highlighting primary and secondary prevention strategies. In addition, we will discuss updates and critical review of newer diagnostic imaging modalities, use of newer therapeutic strategies based on recent clinical trials, and emerging interventional techniques for CVD. • Lastly, topics will be discussed pertaining to reviews on recent clinical trials and practice guidelines in the management of hypertension, dyslipidemia, diabetes mellitus atrial fibrillation, valvular heart disease, syncope, the role of device therapy in HF.

    FIles Avalable

    01_Deedwania_CKM.pdf
    02_Kim_Obesity.pdf
    03_Wong_Epidemiology.pdf
    04_Kim_GLP1s for Obesity.pdf
    05_Wong_CV Risk Assessment.pdf
    06_Crawford_Techniques Heart Sounds & Murmurs.pdf
    07_Daniele_Menopause and HD.pdf
    08_Crawford_Valvular Heart Disorders.pdf
    09_Wong_Cholesterol Mgt.pdf
    10_Daniele_Stress testing CAD.pdf
    11_Lee_ECGs.pdf
    12_Deedwania_HF.pdf
    13_Lee_Advances In EP.pdf
    14_Buhari_Case Presentations.pdf
    15_Lee_A Fib.pdf
    16 COmplete sylabus